IMC Chicago
DNA icon

IMC Chicago’s Ginkgo Bioworks DNA Stock Holding History

IMC Chicago’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Buy
24,311
+3,810
+19% +$31.9K ﹤0.01% 5463
2026
Q1 		$126K Buy
+20,501
New +$171K ﹤0.01% 5251

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

IMC Chicago's DNA Position: Q2 2026 in Review

IMC Chicago increased its Ginkgo Bioworks (DNA) stake by 19% in Q2 2026, buying an estimated $31.9K and bringing the position to 24,311 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #5463.

IMC Chicago first reported a position in DNA in Q1 2026 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • IMC Chicago held 24,311 shares of Ginkgo Bioworks worth $241K as of Q2 2026.
  • IMC Chicago bought 3,810 Ginkgo Bioworks shares in Q2 2026, an estimated $31.9K.
  • Ginkgo Bioworks made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5463 holding.
  • IMC Chicago first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.